Skip to main content

Table 1 Characteristics of epithelial ovarian cancer patients in the training cohort

From: Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer

Exercise group

 

Number of patients

40

Age (years old)

56.5(39–75)

Pretreatment CA-125 (U/ml)

889(153–7561)

Histology: Serous carcinoma

40(100%)

FIGO stage: Advanced

40(100%)

Tumor grade: high

40(100%)

Debulking surgery

 

 R0

13(32.5%)

 R1

27(67.5%)

Platinum response

 

 Sensitive

23(57.5%)

 Resistant

17(42.5%)

Recurrence

 

 Yes

31(77.5%)

 No

9(22.5%)

Death

 

 Yes

21(52.5%)

 No

19(47.5%)

  1. Note: Data of age and CA-125 are presented as median (minimum-maximum), whereas those of other parameters are presented as number (percentage). CA-125, cancer antigen 125; FIGO, International Federation of Gynecology and Obstetrics